Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 28 Show results per page	View Search Criteria \| Help With Results


1.		Randomized Study of Decitabine in Maintenance Therapy of AML

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Other				2006-0358 NCT00398983

Last Modified: 5/5/2008 First Published: 8/1/2002


2.		Phase III Randomized Study of Low-Dose Decitabine Versus Standard Supportive Care in Elderly Patients With Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				60 and over				Other, Pharmaceutical / Industry				EORTC-06011 SUPERGEN-EORTC-06011, GMDSG-EORTC-06011, NCT00043134, EudraCT-2005-002830


3.		Trial of Decitabine in Patients With Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				65 and over				Pharmaceutical / Industry				DACO-016 NCT00260832

Last Modified: 10/12/2006 First Published: 9/23/2006


4.		Phase I/II Study of Decitabine and Tretinoin in Patients With Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				MSKCC-06054 NCT00382200


5.		Phase I/II Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				0704-07 IUCRO-0185 NCT00477386


6.		Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Other				UPCI 07-008 NCT00715793


7.		LBH589 Plus Decitabine for Myelodysplastic Syndromes or Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				60 and over				Other				08-0172 NCT00691938


8.		Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other, Pharmaceutical / Industry				2007-0450 NCT00791271


9.		A Clinical Pharmacology and Exploratory Study of Decitabine Injection in Myelodysplastic Syndrome.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				20 and over				Pharmaceutical / Industry				CR015406 NCT00796003

Last Modified: 3/30/2007 First Published: 10/25/2004


10.		Phase II Study of Decitabine in Patients With Myeloid Metaplasia With Myelofibrosis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				UCCRC-13327A NCI-6814, 6814, NCT00095784

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute